HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis.

Abstract
IgG and IgM antibodies from the sera of patients with multiple sclerosis (MS) were found to possess amylolytic activity hydrolyzing alpha-(1-->4)-glucosyl linkages of maltooligosaccharides, glycogen, and several artificial substrates. Individual IgM fractions isolated from 54 analyzed patients with the clinically definite diagnoses of MS had approximately three orders of magnitude higher specific amylolytic activity than that for healthy donors, whereas IgG from only a few patients had high amylolytic activity. Strict criteria were used to prove that the amylolytic activity of IgMs and IgGs is their intrinsic property and is not due to any enzyme contamination. Fab fragments produced from IgM and IgG fractions of the MS patients displayed the same amylolytic activity. IgMs from various patients demonstrated different modes of action in hydrolyzing maltooligosaccharides.
AuthorsAndrew N Saveliev, Dina R Ivanen, Anna A Kulminskaya, Nadezhda A Ershova, Tat'yana G Kanyshkova, Valentina N Buneva, Alexander S Mogelnitskii, Boris M Doronin, Olga O Favorova, Georgy A Nevinsky, Kirill N Neustroev
JournalImmunology letters (Immunol Lett) Vol. 86 Issue 3 Pg. 291-7 (May 01 2003) ISSN: 0165-2478 [Print] Netherlands
PMID12706534 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Catalytic
  • Immunoglobulin G
  • Immunoglobulin M
  • Oligosaccharides
  • maltooligosaccharides
  • Amylases
Topics
  • Adult
  • Amylases (metabolism)
  • Antibodies, Catalytic (blood, chemistry, metabolism)
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Humans
  • Hydrolysis
  • Immunoglobulin G (blood, chemistry, metabolism)
  • Immunoglobulin M (blood, chemistry, metabolism)
  • Male
  • Middle Aged
  • Multiple Sclerosis (blood, enzymology, immunology)
  • Oligosaccharides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: